Endocrine Gland Neoplasms D004701

Diseases [C] » Neoplasms [C04] » Neoplasms by Site » Endocrine Gland Neoplasms

Diseases [C] » Endocrine System Diseases [C19] » Endocrine Gland Neoplasms

Description

Tumors or cancer of the ENDOCRINE GLANDS.   MeSH

Hierarchy View

Subtype Terms (9)

Adrenal Gland Neoplasms
38 drugs (27 approved, 11 experimental)

Multiple Endocrine Neoplasia
4 drugs (3 approved, 1 experimental)

Ovarian Neoplasms
863 drugs (252 approved, 611 experimental)

Pancreatic Neoplasms
986 drugs (301 approved, 685 experimental)

Paraneoplastic Endocrine Syndromes
 

Parathyroid Neoplasms
12 drugs (10 approved, 2 experimental)

Pituitary Neoplasms
43 drugs (33 approved, 10 experimental)

Testicular Neoplasms
138 drugs (90 approved, 48 experimental)

Thyroid Neoplasms
205 drugs (124 approved, 81 experimental)


Phase 3 Indicated Drugs (3)

Phase 1 Indicated Drugs (3)


Organization Involved with Phase 4 Indications (4)

Organization Involved with Phase 3 Indications (6)

Organization Involved with Phase 1 Indications (4)

Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.